111 Competitors

YI Stock  USD 7.26  0.39  5.10%   
111 Inc competes with Electrocore LLC, Rein Therapeutics, Neuroone Medical, Dyadic International, and RenovoRx; as well as few others. The company is active under Consumer Staples Distribution & Retail sector as part of Consumer Staples industry. Analyzing 111 competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of 111 to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out 111 Correlation with its peers.

111 vs Elutia Correlation

Almost no diversification

The correlation between 111 Inc and ELUT is 0.91 (i.e., Almost no diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding 111 Inc and ELUT in the same portfolio, assuming nothing else is changed.

Moving together with 111 Stock

  0.81BJ BJs Wholesale Club Earnings Call TodayPairCorr
  0.66DG Dollar General Earnings Call This WeekPairCorr
  0.76KR Kroger Company Earnings Call TodayPairCorr

Moving against 111 Stock

  0.853GX HF FOODS GRPPairCorr
  0.83DTCK Davis CommoditiesPairCorr
  0.79HITI High TidePairCorr
  0.64MSS Maison SolutionsPairCorr
  0.54WBUY WEBUY GLOBAL LTDPairCorr
As of now, 111's Return On Capital Employed is increasing as compared to previous years. The 111's current Return On Equity is estimated to increase to 0.18, while Return On Tangible Assets are projected to decrease to (0.02). As of now, 111's Debt To Assets are decreasing as compared to previous years.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.519.3918.27
Details
Intrinsic
Valuation
LowRealHigh
0.305.9014.78
Details
Naive
Forecast
LowNextHigh
0.157.4816.35
Details
0 Analysts
Consensus
LowTargetHigh
5.425.966.62
Details

111 Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 111 and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of 111 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of 111 Inc does not affect the price movement of the other competitor.

High positive correlations

PYPDNMTC
ELUTECOR
ANVSDYAI
CELUANVS
CELURNTX
ANVSRNTX
  

High negative correlations

ELUTANVS
ELUTDYAI
ELUTSTRR
CELUPYPD
ANVSECOR
PYPDANVS

Risk-Adjusted Indicators

There is a big difference between 111 Stock performing well and 111 Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 111's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ECOR  3.96  0.78  0.18  0.39  3.93 
 10.17 
 21.08 
RNTX  3.59 (0.34) 0.00 (0.17) 0.00 
 8.41 
 22.23 
NMTC  4.33  0.44  0.07 (2.04) 4.81 
 11.84 
 31.34 
DYAI  2.44 (0.14) 0.00  0.37  0.00 
 6.38 
 17.03 
RNXT  3.39 (0.05) 0.00  0.01  3.73 
 7.37 
 22.02 
STRR  1.32 (0.04) 0.00 (0.07) 0.00 
 3.19 
 10.00 
ANVS  3.87 (0.85) 0.00 (2.13) 0.00 
 7.46 
 18.66 
PYPD  2.00  0.17  0.07  0.33  2.34 
 4.79 
 14.82 
CELU  3.24 (0.70) 0.00 (4.13) 0.00 
 9.01 
 26.45 
ELUT  4.96  1.11  0.18 (1.13) 4.65 
 9.78 
 34.20 

Cross Equities Net Income Analysis

Compare 111 Inc and related stocks such as Electrocore LLC, Rein Therapeutics, and Neuroone Medical Tec Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
ECOR(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.7 M)(35.8 M)(55.8 M)(45.1 M)(23.5 M)(17.2 M)(22.2 M)(18.8 M)(11.9 M)(13.7 M)(14.4 M)
RNTX(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(21.2 K)(26.2 K)(27.3 K)(15.7 K)(62.9 M)(56.6 M)(53.8 M)
NMTC(6 K)(14 K)(14 K)(30.6 K)(36.2 K)(62.9 K)(47.8 K)(6.8 M)(6.8 M)(13.6 M)(9.9 M)(10 M)(11.9 M)(12.3 M)(3.6 M)(3.2 M)(3.4 M)
DYAI(190.8 K)1.3 M1.3 M(428.1 K)(6 M)65.8 M(3.6 M)(2.1 M)(5.7 M)(8.3 M)(9.3 M)(13.1 M)(9.7 M)(6.8 M)(5.8 M)(5.2 M)(5 M)
RNXT(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(6.3 M)(9.8 M)(10.2 M)(8.8 M)(7.9 M)(8.3 M)
STRR(13.5 M)(3.3 M)(4.9 M)264 K2.5 M21.6 M14.3 M(35.7 M)736 K(4.6 M)(6.5 M)(3 M)(5.3 M)2.2 M(10.4 M)(12 M)(11.4 M)
ANVS(369.6 K)(4.7 M)(8.3 M)(682.3 K)(682.3 K)(682.3 K)(682.3 K)(682.3 K)(713.9 K)(991 K)(5.5 M)(14.5 M)(25.1 M)(56.2 M)(24.6 M)(22.1 M)(21 M)
PYPD(1.8 M)(1.8 M)(1.8 M)(3.9 M)(8.2 M)(8.2 M)(11.4 M)(54.5 M)5.9 M(6.9 M)(35.3 M)(40.7 M)(39.5 M)(23.9 M)(29 M)(34.2 M)(35.9 M)
CELU(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(211.9 M)(208.2 M)(100.1 M)14.2 M(196.3 M)(57.9 M)(66.6 M)(69.9 M)
ELUT(11.6 M)(11.6 M)(11.6 M)(11.6 M)(11.6 M)(11.6 M)(11.6 M)(11.6 M)(11.6 M)(11.9 M)(21.8 M)(24.8 M)(32.9 M)(37.7 M)(53.9 M)(48.6 M)(46.1 M)

111 Inc and related stocks such as Electrocore LLC, Rein Therapeutics, and Neuroone Medical Tec Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in 111 Inc financial statement analysis. It represents the amount of money remaining after all of 111 Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

111 Competitive Analysis

The better you understand 111 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 111's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 111's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
YI ECOR RNTX NMTC DYAI RNXT STRR ANVS PYPD CELU
 5.10 
 7.26 
111
 5.76 
 7.52 
Electrocore
 0.83 
 1.19 
Rein
 2.47 
 0.83 
Neuroone
 7.32 
 0.76 
Dyadic
 1.18 
 0.84 
RenovoRx
 1.21 
 10.05 
Star
 0.00 
 2.48 
Annovis
 0.71 
 4.22 
PolyPid
 0.00 
 1.20 
Celularity
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

111 Competition Performance Charts

Five steps to successful analysis of 111 Competition

111's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by 111 Inc in relation to its competition. 111's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of 111 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 111's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to 111 Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 111 position

In addition to having 111 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alcohol Thematic Idea Now

Alcohol
Alcohol Theme
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 18 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All  Next Launch
Check out 111 Correlation with its peers.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is there potential for Consumer Staples Distribution & Retail market expansion? Will 111 introduce new products? Factors like these will boost the valuation of 111. Anticipated expansion of 111 directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about 111 listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.86)
Revenue Per Share
1.6 K
Quarterly Revenue Growth
(0.17)
Return On Assets
(0)
Return On Equity
(0.11)
111 Inc's market price often diverges from its book value, the accounting figure shown on 111's balance sheet. Smart investors calculate 111's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since 111's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between 111's value and its price as these two are different measures arrived at by different means. Investors typically determine if 111 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 111's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.